[Inhalation anesthesia in Gelineau syndrome (cataplexy-catalepsy)].
D000762:Anesthesia Recovery Period; D000769:Anesthesia, Inhalation / Q000009:adverse effects; D000932:Antiemetics / Q000627:therapeutic use; D017544:Aortic Aneurysm, Abdominal / Q000150:complications / Q000601:surgery*; D001049:Apnea / Q000517:prevention & control; D006970:Disorders of Excessive Somnolence / Q000517:prevention & control; D005263:Femoral Artery / Q000601:surgery; D005283:Fentanyl; D006212:Hallucinations / Q000209:etiology*; D006801:Humans; D007530:Isoflurane; D008297:Male; D008875:Middle Aged; D016343:Monitoring, Intraoperative; D009290:Narcolepsy / Q000150:complications; D017294:Ondansetron / Q000627:therapeutic use; D020447:Parasomnias / Q000209:etiology*; D011183:Postoperative Complications / Q000209:etiology* / Q000517:prevention & control; D015742:Propofol; D020188:Sleep Paralysis / Q000517:prevention & control
D000932:Antiemetics; D017294:Ondansetron; D007530:Isoflurane; D005283:Fentanyl; D015742:Propofol
Anestesia inhalatoria en el síndrome de Gelineau (cataplejia-catalepsia).